THE CONOLIDINE DIARIES

These effects, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assist the notion of concentrating on ACKR3 as a unique approach to modulate the opioid program, which could open new therapeutic avenues for opioid-connected Conditions.These final results advise that conolidine